GoodRx Holdings, Inc. (GDRX)
3.28
+0.01
(+0.31%)
USD |
NASDAQ |
Oct 02, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
GoodRx Holdings Cash from Operations (TTM) : 201.58M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 201.58M |
| March 31, 2026 | 170.33M |
| December 31, 2025 | 167.90M |
| September 30, 2025 | 179.76M |
| June 30, 2025 | 190.60M |
| March 31, 2025 | 150.72M |
| December 31, 2024 | 183.89M |
| September 30, 2024 | 155.02M |
| June 30, 2024 | 128.42M |
| March 31, 2024 | 148.59M |
| December 31, 2023 | 138.29M |
| Date | Value |
|---|---|
| September 30, 2023 | 154.30M |
| June 30, 2023 | 127.76M |
| March 31, 2023 | 148.95M |
| December 31, 2022 | 146.78M |
| September 30, 2022 | 164.71M |
| June 30, 2022 | 179.54M |
| March 31, 2022 | 163.41M |
| December 31, 2021 | 178.78M |
| September 30, 2021 | 143.82M |
| June 30, 2021 | 127.93M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| LataMed AI Corp. | -0.2553M |
| SCWorx Corp. | -0.7456M |
| Health Catalyst, Inc. | 28.23M |
| Claritev Corp. | 133.04M |
| iSpecimen, Inc. | -7.004M |